Pasithea Therapeutics Corp
(KTTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,174 | -2,804 | -1,278 | -550 | -41 |
| Depreciation Amortization | 1 | N/A | N/A | N/A | 0 |
| Other Working Capital | 111 | 57 | 97 | 168 | 2 |
| Other Operating Activity | -1,113 | 1,317 | 300 | 0 | 0 |
| Operating Cash Flow | $-3,174 | $-1,430 | $-881 | $-382 | $-39 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22 | -9 | N/A | N/A | 0 |
| Investing Cash Flow | $-22 | $-9 | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 57,237 | 23,071 | 1,209 | 1,209 | N/A |
| Other Financing Activity | -1,307 | -1,307 | 0 | 0 | 282 |
| Financing Cash Flow | $55,929 | $21,764 | $1,209 | $1,209 | $282 |
| Exchange Rate Effect | -11 | -4 | -2 | N/A | 0 |
| Beginning Cash Position | 244 | 244 | 244 | 244 | 0 |
| End Cash Position | 52,967 | 20,565 | 569 | 1,071 | 244 |
| Net Cash Flow | $52,723 | $20,322 | $325 | $827 | $244 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,174 | -1,430 | -881 | -382 | -39 |
| Capital Expenditure | -22 | -9 | 0 | N/A | N/A |
| Free Cash Flow | -3,196 | -1,438 | -881 | -382 | -39 |